RU2446159C2 - Антибактериальные производные хинолина - Google Patents

Антибактериальные производные хинолина Download PDF

Info

Publication number
RU2446159C2
RU2446159C2 RU2009125525/04A RU2009125525A RU2446159C2 RU 2446159 C2 RU2446159 C2 RU 2446159C2 RU 2009125525/04 A RU2009125525/04 A RU 2009125525/04A RU 2009125525 A RU2009125525 A RU 2009125525A RU 2446159 C2 RU2446159 C2 RU 2446159C2
Authority
RU
Russia
Prior art keywords
alkyl
formula
compound
aryl
compounds
Prior art date
Application number
RU2009125525/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2009125525A (ru
Inventor
Жером Эмиль Жорж ГИЙЕМОН (FR)
Жером Эмиль Жорж Гийемон
Магали Мадлен Симон МОТТ (FR)
Магали Мадлен Симон Мотт
Кунрад Йозеф Лодевейк Марсель АНДРИС (BE)
Кунрад Йозеф Лодевейк Марсель Андрис
Анил КОУЛ (BE)
Анил Коул
Original Assignee
Янссен Фармацевтика Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Янссен Фармацевтика Н.В. filed Critical Янссен Фармацевтика Н.В.
Publication of RU2009125525A publication Critical patent/RU2009125525A/ru
Application granted granted Critical
Publication of RU2446159C2 publication Critical patent/RU2446159C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
RU2009125525/04A 2006-12-06 2007-12-04 Антибактериальные производные хинолина RU2446159C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06125521.2 2006-12-06
EP06125521 2006-12-06

Publications (2)

Publication Number Publication Date
RU2009125525A RU2009125525A (ru) 2011-01-20
RU2446159C2 true RU2446159C2 (ru) 2012-03-27

Family

ID=37944337

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2009125525/04A RU2446159C2 (ru) 2006-12-06 2007-12-04 Антибактериальные производные хинолина

Country Status (29)

Country Link
US (1) US7998979B2 (enExample)
EP (1) EP2086941B1 (enExample)
JP (1) JP5356245B2 (enExample)
KR (1) KR101490221B1 (enExample)
CN (1) CN101541752B (enExample)
AR (1) AR064150A1 (enExample)
AT (1) ATE465994T1 (enExample)
AU (1) AU2007328889B2 (enExample)
BR (1) BRPI0720251B8 (enExample)
CA (1) CA2668520C (enExample)
CL (1) CL2007003516A1 (enExample)
CY (1) CY1110706T1 (enExample)
DE (1) DE602007006231D1 (enExample)
DK (1) DK2086941T3 (enExample)
ES (1) ES2344535T3 (enExample)
HR (1) HRP20100384T1 (enExample)
IL (1) IL199081A (enExample)
JO (1) JO2685B1 (enExample)
ME (1) ME01073B (enExample)
MX (1) MX2009005980A (enExample)
NO (1) NO341995B1 (enExample)
NZ (1) NZ576673A (enExample)
PL (1) PL2086941T3 (enExample)
PT (1) PT2086941E (enExample)
RS (1) RS51390B (enExample)
RU (1) RU2446159C2 (enExample)
SI (1) SI2086941T1 (enExample)
TW (1) TWI412364B (enExample)
WO (1) WO2008068269A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9133167B2 (en) 2012-04-27 2015-09-15 Janssen Pharmaceutica Nv Antibacterial quinoline derivatives
KR102110366B1 (ko) 2012-04-27 2020-05-14 얀센 파마슈티카 엔.브이. 항균성 퀴놀린 유도체
CN104650054B (zh) * 2013-11-25 2019-09-13 重庆医药工业研究院有限责任公司 一种抗结核菌的喹啉噻吩芳氧乙胺衍生物
US11857352B2 (en) 2016-09-06 2024-01-02 The Research Foundation For The State University Of New York Positron imaging tomography imaging agent composition and method for bacterial infection
KR20240161147A (ko) 2022-03-14 2024-11-12 슬랩 파마슈티컬스 엘엘씨 다중 사이클릭 화합물

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1452455A3 (ru) * 1979-02-22 1989-01-15 Ниссан Кемикал Индастриз Лтд (Фирма) Гербицидна композици (ее варианты)
UA75691C2 (en) * 2001-07-31 2006-05-15 Univ Wayne State Quinoline derivatives, use thereof as antitumor drugs, composition based thereon and therapeutical method for treatment of cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965572A (en) 1996-10-28 1999-10-12 The United States Of America As Respresented By The Secretary Of The Army Methods for treating antibiotic-resistant infections
PT1527050E (pt) * 2002-07-25 2010-06-22 Janssen Pharmaceutica Nv Derivados de quinolina e sua utilização como inibidores de micobactérias
KR101150172B1 (ko) 2004-01-23 2012-05-25 얀센 파마슈티카 엔.브이. 치환된 퀴놀린 및 마이코박테리아 저해제로서의 용도
ATE444068T1 (de) * 2004-01-23 2009-10-15 Janssen Pharmaceutica Nv Chinolinderivate und ihre verwendung als mycobakterielle inhibitoren
MXPA06008596A (es) * 2004-01-29 2006-08-28 Janssen Pharmaceutica Nv Derivados de quinolina para uso como inhibidores micobacterianos.
JO2524B1 (en) * 2004-05-28 2010-03-17 جانسن فارمسيتكا ان في Use of substituted quinoline derivatives to treat drug-resistant microbial diseases
KR101539021B1 (ko) 2004-09-28 2015-07-23 얀센 파마슈티카 엔.브이. 박테리아 ａｔｐ 합성효소 결합 부분

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1452455A3 (ru) * 1979-02-22 1989-01-15 Ниссан Кемикал Индастриз Лтд (Фирма) Гербицидна композици (ее варианты)
UA75691C2 (en) * 2001-07-31 2006-05-15 Univ Wayne State Quinoline derivatives, use thereof as antitumor drugs, composition based thereon and therapeutical method for treatment of cancer

Also Published As

Publication number Publication date
EP2086941B1 (en) 2010-04-28
BRPI0720251A2 (pt) 2014-01-07
KR20090087071A (ko) 2009-08-14
CA2668520C (en) 2016-01-26
PT2086941E (pt) 2010-07-14
HK1137428A1 (en) 2010-07-30
BRPI0720251B8 (pt) 2021-05-25
CN101541752B (zh) 2013-07-17
JP2010511670A (ja) 2010-04-15
MX2009005980A (es) 2009-06-16
AR064150A1 (es) 2009-03-18
JO2685B1 (en) 2013-03-03
NO20092540L (no) 2009-09-07
DE602007006231D1 (de) 2010-06-10
AU2007328889A1 (en) 2008-06-12
WO2008068269A1 (en) 2008-06-12
NZ576673A (en) 2011-09-30
TWI412364B (zh) 2013-10-21
IL199081A (en) 2013-08-29
RU2009125525A (ru) 2011-01-20
US7998979B2 (en) 2011-08-16
ME01073B (me) 2012-10-20
NO341995B1 (no) 2018-03-12
BRPI0720251B1 (pt) 2020-10-06
ATE465994T1 (de) 2010-05-15
DK2086941T3 (da) 2010-08-09
KR101490221B1 (ko) 2015-02-05
CN101541752A (zh) 2009-09-23
CY1110706T1 (el) 2015-06-10
RS51390B (sr) 2011-02-28
JP5356245B2 (ja) 2013-12-04
SI2086941T1 (sl) 2010-08-31
ES2344535T3 (es) 2010-08-30
CL2007003516A1 (es) 2008-07-11
HRP20100384T1 (hr) 2010-08-31
PL2086941T3 (pl) 2010-10-29
AU2007328889B2 (en) 2012-12-06
TW200845987A (en) 2008-12-01
US20100063061A1 (en) 2010-03-11
EP2086941A1 (en) 2009-08-12
CA2668520A1 (en) 2008-06-12

Similar Documents

Publication Publication Date Title
JP5466011B2 (ja) 抗菌性キノリン誘導体
EP2099762B1 (en) Antibacterial quinoline derivatives
AU2006274880B2 (en) Quinoline derivatives as antibacterial agents
EP2099759B1 (en) Antibacterial quinoline derivatives
JP5356245B2 (ja) 抗菌性キノリン誘導体
JP5466012B2 (ja) 抗菌性キノリン誘導体
JP5466013B2 (ja) 抗菌性キノリン誘導体
HK1137428B (en) Antibacterial quinoline derivatives
HK1208437B (zh) 抗菌的喹啉衍生物
EA040841B1 (ru) Антибактериальные производные хинолина
HK1137431B (en) Antibacterial quinoline derivatives